Search hospitals > Iowa > Cedar Rapids
Oncology Associates at Mercy Medical Center
Claim this profileCedar Rapids, Iowa 52403
Global Leader in Breast Cancer
Global Leader in Skin Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
291 reported clinical trials
1 medical researcher
Summary
Oncology Associates at Mercy Medical Center is a medical facility located in Cedar Rapids, Iowa. This center is recognized for care of Breast Cancer, Skin Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Oncology Associates at Mercy Medical Center is involved with conducting 291 clinical trials across 363 conditions. There are 1 research doctors associated with this hospital, such as Deborah W. Wilbur.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Skin Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Clinical Trials running at Oncology Associates at Mercy Medical Center
Breast Cancer
Skin Cancer
Breast cancer
Lung Cancer
Ovarian Cancer
Squamous Cell Carcinoma
Throat Cancer
Oropharyngeal Carcinoma
Laryngeal Cancer
Prostate Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Oncology Associates at Mercy Medical Center?
Oncology Associates at Mercy Medical Center is a medical facility located in Cedar Rapids, Iowa. This center is recognized for care of Breast Cancer, Skin Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Oncology Associates at Mercy Medical Center is involved with conducting 291 clinical trials across 363 conditions. There are 1 research doctors associated with this hospital, such as Deborah W. Wilbur.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.